Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

AstraZeneca Pressured by Generics
Trading Markets
Saturday, November 1, 2008 - 12:03pm
tags:
Acomplia's EU suspension dispels illusion of blockbuster future
PipeLine Review
Saturday, November 1, 2008 - 12:02pm
tags:
Actavis signs distribution agreement with J&M Pharma Co. Ltd in South Korea
PR-Canada.net
Saturday, November 1, 2008 - 12:02pm
tags:
Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
MarketWatch
Saturday, November 1, 2008 - 12:01pm
tags:
FDA approves drug distributed by Pfizer
TheDay, CT
Saturday, November 1, 2008 - 12:00pm
tags:
Zydus drags Teva to court
Merinews, India
Saturday, November 1, 2008 - 11:56am
tags:
Less Is More For Sanofi
Forbes.com
Saturday, November 1, 2008 - 11:54am
tags:
Spectrum Pharmaceuticals files sNDA for Fusilev in colorectal cancer
Pharmaceutical Business Review
Saturday, November 1, 2008 - 11:53am
tags:
Daiichi Sankyo to dissolve subsidiaries with Sanofi-Aventis
Pharmaceutical Business Review
Saturday, November 1, 2008 - 11:29am
tags:
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Red Orbit
Saturday, November 1, 2008 - 11:26am
tags:
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
PR NewsWire
Saturday, November 1, 2008 - 11:23am
tags:
Drug Stock Short Stories
Forbes
Saturday, November 1, 2008 - 10:31am
tags:
FDA approves Schwarz, Pfizer overactive bladder drug
Marketwatch
Saturday, November 1, 2008 - 10:30am
tags:
Disease Is Good for Novo Nordisk
Motley Fool
Saturday, November 1, 2008 - 10:29am
tags:
Arena: No Near-Term Relief
Yahoo/Zacks.com
Friday, October 31, 2008 - 10:28am
tags:
Inspire's losses narrow on higher sales
Bizjournals.com
Friday, October 31, 2008 - 10:27am
tags:
Hot Small Caps: Shire leads gainers in pharma sector
Reuters, UK
Friday, October 31, 2008 - 10:02am
tags:
Sanofi best-sellers help lift net profit in 3Q
Yahoo/AP
Friday, October 31, 2008 - 10:00am
tags:
Insurers entice doctors to prescribe generic drugs
Google/AP
Friday, October 31, 2008 - 9:59am
tags:
Pension Fund Thinks Lilly / Imclone Deal Too Cheap
Seeking Alpha
Friday, October 31, 2008 - 9:58am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information